Company profile
Vicore Pharma company profile
Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EU and the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Business identity
- Website
- http://vicorepharma.com
- Phone number
- +46 (0) 31 788 05 60
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2009-01-01, Year
Headquarters
- Headquarters
- Mölndal, Västra Götaland, Sweden
- Postal code
- 413 83
- Country code
- SE
- Continent
- Europe